These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18719506)

  • 1. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    J Clin Gastroenterol; 2008 Oct; 42(9):1047-53. PubMed ID: 18719506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis.
    Montano-Loza A; Czaja AJ; Carpenter HA; Piette A; Murphy D; Shums Z; Burlingame R; Norman GL
    Autoimmunity; 2006 Jun; 39(4):341-8. PubMed ID: 16891223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study.
    Mishima S; Omagari K; Ohba K; Kadokawa Y; Masuda J; Mishima R; Kinoshita H; Hayashida K; Isomoto H; Shikuwa S; Mizuta Y; Kohno S
    Hepatogastroenterology; 2008; 55(81):221-7. PubMed ID: 18507111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features and consequences of untreated type 1 autoimmune hepatitis.
    Czaja AJ
    Liver Int; 2009 Jul; 29(6):816-23. PubMed ID: 19018980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.
    Nezu S; Tanaka A; Yasui H; Imamura M; Nakajima H; Ishida H; Takahashi S
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1448-54. PubMed ID: 16911691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis.
    Farias AQ; Gonçalves LL; Bittencourt PL; De Melo ES; Abrantes-Lemos CP; Porta G; Nakhle MC; Carrilho FJ; Cancado EL
    J Gastroenterol Hepatol; 2006 May; 21(5):887-93. PubMed ID: 16704541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature.
    Ramos-Casals M; Pares A; Jara LJ; Solans R; Viñas O; Vázquez P; Sánchez-Tapias JM; Rodés J; Font J;
    J Viral Hepat; 2005 Nov; 12(6):648-54. PubMed ID: 16255767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.
    Granito A; Muratori L; Pappas G; Muratori P; Ferri S; Cassani F; Lenzi M; Bianchi FB
    Aliment Pharmacol Ther; 2005 May; 21(10):1273-7. PubMed ID: 15882249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT; Lohse AW
    Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis.
    Mehendiratta V; Mitroo P; Bombonati A; Navarro VJ; Rossi S; Rubin R; Herrine SK
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):98-103. PubMed ID: 18955163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Liver Int; 2006 Dec; 26(10):1201-8. PubMed ID: 17105585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune hepatitis: clinical forms and related factors to their response to treatment].
    Dávalos M; Román R; Bustios C; Zumaeta E; Yabar A
    Rev Gastroenterol Peru; 2004; 24(4):305-13. PubMed ID: 15614298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Shums Z; Norman GL; Czaja AJ
    Liver Int; 2012 Jan; 32(1):85-92. PubMed ID: 21745277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of treatment withdrawal in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Liver Int; 2007 May; 27(4):507-15. PubMed ID: 17403191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis with incidental histologic features of bile duct injury.
    Czaja AJ; Carpenter HA
    Hepatology; 2001 Oct; 34(4 Pt 1):659-65. PubMed ID: 11584360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
    Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
    Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study.
    Muratori P; Efe C; Muratori L; Ozaslan E; Schiano T; Yoshida EM; Heurgué-Berlot A; Lalanne C; Lenzi M; Wahlin S
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):777-780. PubMed ID: 28328618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.